|
Tuesday, 10 May 2011 07:55 |
|
The technology could be used to make parts that perform better and cost less.
GE is starting a new lab at its global research headquarters in Niskayuna, New York, that's devoted to turning three-dimensional printing technology into a viable means of manufacturing functional parts for a range of its businesses, including those involving health care and aerospace. The company aims to take advantage of the technology's potential to make parts that are lighter, perform better, and cost less than parts made with conventional manufacturing techniques.
|
|
Read more...
|
|
Thursday, 05 May 2011 23:58 |
|
Swiss ESBATech spin-out Delenex has boosted its Series A VC financing by EUR13m, now totalling EUR23.5m, with help of its new investor Novo Ventures. The company said this would be enough money to bring its lead product DLX105 to clinical proof of concept. DLX105 is a stabilised humanised anti-TNFalpha single-chain Fv monoclonal antibody originally developed by Delenex mother company ESBATech, for which Delenex has an exclusive licence in non-ophtalmolic indications.
|
|
Read more...
|
|
Thursday, 05 May 2011 22:54 |
|
The company says the new architecture will result in better performance with less power.
Intel has shown off the design of its next generation of chips. The new transistor design, which uses a three-dimensional gate rather than a flat one, will go into production at the company's fabs over the next year. The company says the three-dimensional structure will allow the company to double the density of its chips while also providing performance gains and lower power consumption.
|
|
Read more...
|
|
Tuesday, 03 May 2011 06:30 |
|
A leading biofuels company will begin making farnesene for cosmetics and fuel in Brazil.
Amyris, a biofuels company based in Emeryville, California, announced that it is about to start commercial production of a chemical called farnesene, which can be used to make cosmetics, lubricants, and diesel and jet fuel. The company, which makes the chemical using genetically engineered yeast, is buying dedicated access to three 200,000-liter fermentors owned by a Brazilian company that makes food products for animals. The fermentors, which will start production in May, can produce up to 17 million liters of farnesene per year.
|
|
Read more...
|
|
Saturday, 30 April 2011 05:23 |
|
Immune therapy proves effective against melanoma in an early trial.
Melanoma, one of the most common cancers, is usually treated with surgery and aggressive chemotherapy. In a new, preliminary study, Dr. Marcus O. Butler, of Boston's Dana-Farber Cancer Institute, suggests a kinder, gentler way of treating melanoma, and perhaps other cancers, using the body's own defense system.
In a study published in the April 27 edition of Science Translational Medicine, Butler and his colleagues harvested immune cells from nine patients. They souped up the cells in their lab—in effect giving them the ability to remember cancer cells—multiplied them in number, and infused them back into the patients from whom they been taken.
|
|
Read more...
|
|
Saturday, 30 April 2011 05:15 |
|
A new nerve-cell-support design could give amputees better control over prosthetic limbs.
To design prosthetic limbs with motor control and a sense of touch, researchers have been looking at ways to connect electrodes to nerve endings on the arm or leg and then to translate signals from those nerves into electrical instructions for moving the mechanical limb. However, severed nerve cells on an amputated limb can only grow if a structure is present to support them—much the way a trellis supports a growing vine. And they are notoriously fussy about the shape and size of that structure.
|
|
Read more...
|
|
Tuesday, 26 April 2011 02:34 |
|
In his new book Biopunk: DIY Scientists Hack the Software of Life, Marcus Wohlsen explores the new movement in garage-based biotech.
For most of us, managing our health means visiting a doctor. The more serious our concerns, the more specialized a medical expert we seek. Our bodies often feel like foreign and frightening lands, and we are happy to let someone with an MD serve as our tour guide. For most of us, our own DNA never makes it onto our personal reading list.
|
|
Read more...
|
|
Thursday, 21 April 2011 20:11 |
|
A new startup, funded with $40 million from Third Rock Ventures, will develop drugs aimed at molecularly defined cancers.
Blueprint Medicines, a startup based in Cambridge, Massachusetts, plans to use the growing amount of genomic information about cancer to create new drugs targeted at the mechanisms that drive specific subtypes of the disease. The company, which announced its creation last week with $40 million in funding from Third Rock Ventures, reflects a growing trend toward defining cancers not by their location in the body but by the particular collections of genetic mistakes that enable tumor cells to grow out of control.
|
|
Read more...
|
|
Thursday, 21 April 2011 19:42 |
|
The clear rubber chip sitting under a microscope in Stephen Quake’s lab is a complex maze of tiny channels, chambers, and pumps, hooked up to thin plastic tubes that supply reagents and control 650-plus minuscule valves. Using this microfluidic chip, Quake, a biophysicist at Stanford University, has engineered a way of obtaining data that’s missing from nearly all human genome sequences: which member of a pair of chromosomes a gene belongs to.
|
|
Read more...
|
|
Tuesday, 19 April 2011 06:21 |
|
A new technique can make tailor-made proteins evolve in days, not years.
By exploiting the rapid replicating power of viruses, researchers were able to make biological molecules in the laboratory evolve much more rapidly than they can with existing approaches. Their new method, called phage-assisted continuous evolution (PACE), could be used to accelerate the development of therapeutic proteins, such as new cancer drugs, or to tackle unsolved questions about how evolution works.
|
|
Read more...
|
|
|
Tuesday, 10 May 2011 07:45 |
|
As yet another biofuels company prepares for a stock offering, some wonder if the company is worthy of going public at all.
In 2004, a startup called Nanosys tried to go public. It had recruited some of the world's top nanoscientists for its board and had bought up hundreds of nanotech patents. The idea was that it could revolutionize TV displays, batteries, and maybe even golf balls. It had no product, but so what? Nanotech seemed like it could change everything.
That is when a venture capitalist named Vinod Khosla, then with Kleiner, Perkins, Caufield & Byers, cried fraud. A speech of Khosla's at Stanford University helped to not only torpedo the Nanosys IPO but also burst a short-lived nanotech bubble.
|
|
Read more...
|
|
Thursday, 05 May 2011 23:32 |
|
New energy-storage technology could surpass today's batteries in capacity and durability.
A startup called Nanotune says its ultracapacitor technology could make electric cars cheaper and extend their range. The company, based in Mountain View, California, has developed a way to make electrodes that results in ultracapacitors with five to seven times as much storage capacity as conventional ones.
Conventional ultracapacitors, which have the advantage of delivering fast bursts of power and can be recharged hundreds of thousands of times without losing much capacity, are too expensive and store too little energy to replace batteries.
|
|
Read more...
|
|
Tuesday, 03 May 2011 06:33 |
|
Battery draws power from salinity difference between freshwater and saltwater.
The difference in salinity between freshwater and saltwater holds promise as a large source of renewable energy. Energy is required to desalinate water, and running the process in reverse can generate energy. Now a novel approach based on a conventional battery design that uses nanomaterials could provide a way to harvest that energy economically.
The new device, developed by researchers at Stanford University, consists of an electrode that attracts positive sodium ions and one that attracts negative chlorine ions.
|
|
Read more...
|
|
Tuesday, 03 May 2011 06:27 |
|
A startup says technology inspired by RAID hard drives can boost power output by up to 50 percent.
A startup called TenKsolar, based in Minneapolis, says it can increase the amount of solar power generated on rooftops by 25 to 50 percent, and also reduce the overall cost of solar power by changing the way solar cells are wired together and adding inexpensive reflectors to gather more light.
TenKsolar says its systems can produce power for as little as eight cents a kilowatt-hour in sunny locations. That's significantly more expensive than electricity from typical coal or natural-gas power plants, but it is less than the average price of electricity in the United States.
|
|
Read more...
|
|
Saturday, 30 April 2011 05:20 |
|
Delivering light-sensitive proteins to the retinas of blind mice restores some vision.
Viruses can deliver light-sensitive proteins to specific cells in the retinas of blind mice, allowing rudimentary vision, according to new research. Although previous studies have shown that the light-sensitive proteins can be beneficial, the delivery methods were not practical for humans. The viral-delivery method is similar to ones already used in human gene therapy.
The new light-sensitive proteins were active for the length of the study, about 10 months, suggesting the treatment would work long-term. In addition, the therapy appeared safe; the proteins, which were derived from algae, remained within the eye, and they did not trigger inflammation.
|
|
Read more...
|
|
Tuesday, 26 April 2011 02:37 |
|
A startup is developing a simple ultrasound method to get cancer drugs into the brain.
The cells lining the brain's blood vessels are tightly packed together—like a good defensive line, they keep bacteria and other blood-borne intruders from getting through, shielding the brain. But this protective layer, called the blood-brain barrier, also thwarts efforts to deliver drugs like chemotherapy agents to the brain, so scientists have long searched for ways to disrupt it selectively to allow treatments in. A startup company called Perfusion Technology is developing a technique to open this barrier by bathing the brain in ultrasound waves.
|
|
Read more...
|
|
Tuesday, 26 April 2011 02:30 |
|
A nonprofit creates a new heart monitoring machine employing wireless technology.
An inexpensive portable device could make it easy to monitor fetal health in remote locations, and it might also provide an alternative to more expensive machines currently used in doctors' offices in the developed world.
The device, a cardiotocography machine dubbed Sense4Baby, was designed by engineers at the nonprofit West Wireless Health Institute, a medical research organization whose mission is to use wireless technology to reduce the cost of health care.
|
|
Read more...
|
|
Thursday, 21 April 2011 20:02 |
|
Designing new genomes could speed the creation of vaccines and biofuel-producing bacteria
The bacteria growing on stacks of petri dishes in Daniel Gibson's lab are the first living creatures with a completely artificial genome. The microbes' entire collection of genes was edited on a computer and assembled by machines that create genetic fragments from chemicals and by helper cells that pieced those fragments together. Gibson hopes that being able to design and create entire genomes, instead of just short lengths of DNA, will dramatically speed up the process of engineering microbes that can carry out tasks such as efficiently producing biofuels or vaccines.
|
|
Read more...
|
|
Tuesday, 19 April 2011 06:26 |
|
The automaker aims to bring a cheap hybrid technology used in some large vehicles to passenger cars.
The U.S. Environmental Protection Agency and Chrysler Group have partnered to test a hydraulic hybrid system for minivans that could be cheaper than conventional hybrid systems and could save more gasoline. EPA and Chrysler are each spending $2 million (for a total of $4 million) on the project, and they expect to begin road testing next year.
Conventional hybrids save gas in part by using energy from braking to charge a battery. A hydraulic hybrid captures energy by using a hydraulic pump instead of conventional friction brakes to slow the vehicle. The pump forces fluid into a tank, compressing air that can then be used to help propel the vehicle.
|
|
Read more...
|
|
Tuesday, 19 April 2011 06:14 |
|
A startup has developed a device that uses magnetic particles to identify pathogens rapidly.
A startup called T2 Biosystems is developing a test that uses magnetic nanoparticles to detect blood-borne infections in hours—compared to the days it now takes using conventional lab methods. The company's first device—about the size of a printer—will target Candida, a fungus that is the third-most-common cause of hospital-acquired infections. The detection system can identify Candida in human blood samples in about two hours. Clinical trials involving samples from actual patients are in the works.
|
|
Read more...
|
|